d-amino acid oxidase knockout (Dao−/−) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption

Circadian abnormalities in a mouse model of high trait anxiety and depression

(2014) Irene Griesauer et al.   ANNALS OF MEDICINE

Natural Neural Projection Dynamics Underlying Social Behavior

(2014) Lisa A. Gunaydin et al.   CELL

Increased burst-firing of ventral tegmental area dopaminergic neurons ind-amino acid oxidase knockout micein vivo

(2014) Judith V. Schweimer et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Enhancing the value of psychiatric mouse models; differential expression of developmental behavioral and cognitive profiles in four inbred strains of mice

(2014) Remco T. Molenhuis et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A human sleep homeostasis phenotype in mice expressing a primate-specific PER3 variable-number tandem-repeat coding-region polymorphism

(2014) Sibah Hasan et al.   FASEB JOURNAL

Hippocampal synaptic plasticity, spatial memory and anxiety

(2014) David M. Bannerman et al.   NATURE REVIEWS NEUROSCIENCE

Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

(2013) Chieh-Hsin Lin et al.   BIOLOGICAL PSYCHIATRY

D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy

(2013) Silvia Sacchi et al.   CURRENT PHARMACEUTICAL DESIGN

Retinal NMDA receptor function and expression are altered in a mouse lacking d-amino acid oxidase

(2013) Eric C. Gustafson et al.   JOURNAL OF NEUROPHYSIOLOGY

NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: A meta-analysis of case–control studies

(2013) Annelies Brouwer et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Add-on Treatment of Benzoate for Schizophrenia

(2013) Hsien-Yuan Lane et al.   JAMA Psychiatry

d-Amino acids in the brain and mutant rodents lacking d-amino-acid oxidase activity

(2012) Masahiro Yamanaka et al.   AMINO ACIDS

Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists

(2012) Thomas Papouin et al.   CELL

Disrupted Circadian Rhythms in a Mouse Model of Schizophrenia

(2012) Peter L. Oliver et al.   CURRENT BIOLOGY

Rapid Assessment of Sleep-Wake Behavior in Mice

(2012) Simon P. Fisher et al.   JOURNAL OF BIOLOGICAL RHYTHMS

Sleep Phenotyping in a Mouse Model of Extreme Trait Anxiety

(2012) Vladimira Jakubcakova et al.   PLoS One

NMDA Receptor and Schizophrenia: A Brief History

(2012) J. T. Coyle   SCHIZOPHRENIA BULLETIN

Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: Evidence from genetically modified mouse models and pharmacological inhibition

(2011) Hanns Möhler et al.   BIOCHEMICAL PHARMACOLOGY

Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia

(2011) Dana V. Ferraris et al.   CURRENT PHARMACEUTICAL DESIGN

Contributions of the d-serine pathway to schizophrenia

(2011) Viviane Labrie et al.   NEUROPHARMACOLOGY

The Association of Schizophrenia Risk D-Amino Acid Oxidase Polymorphisms With Sensorimotor Gating, Working Memory and Personality in Healthy Males

(2011) Panos Roussos et al.   NEUROPSYCHOPHARMACOLOGY

Effects of low-dose d-serine on recognition and working memory in mice

(2011) Patricia Bado et al.   PSYCHOPHARMACOLOGY

Behavioral characterization of a mutant mouse strain lacking d-amino acid oxidase activity

(2010) Min Zhang et al.   BEHAVIOURAL BRAIN RESEARCH

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?

(2010) Joshua T. Kantrowitz et al.   BRAIN RESEARCH BULLETIN

Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice

(2010) Samantha J. Line et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

High dose D-serine in the treatment of schizophrenia

(2010) Joshua T. Kantrowitz et al.   SCHIZOPHRENIA RESEARCH

Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model

(2009) Viviane Labrie et al.   HUMAN MOLECULAR GENETICS

Increased d-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study

(2009) Gregor Habl et al.   JOURNAL OF NEURAL TRANSMISSION

Potential pathophysiological role of d-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain

(2009) Koji Ono et al.   JOURNAL OF NEURAL TRANSMISSION

Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice

(2009) V. Labrie et al.   LEARNING & MEMORY

Glutamatergic (N-Methyl-D-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain?

(2009) G. J. Marek et al.   MOLECULAR PHARMACOLOGY

The neurobiology of D-amino acid oxidase and its involvement in schizophrenia

(2009) L Verrall et al.   MOLECULAR PSYCHIATRY

Candidate genes for schizophrenia: A survey of association studies and gene ranking

(2008) Jingchun Sun et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

The Behavioral and Neurochemical Effects of a Novel D-Amino Acid Oxidase Inhibitor Compound 8 [4H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and D-Serine

(2008) S. M. Smith et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

D-Amino acid oxidase activity and expression are increased in schizophrenia

(2008) P W J Burnet et al.   MOLECULAR PSYCHIATRY

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior

(2008) A C Basu et al.   MOLECULAR PSYCHIATRY

Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database

(2008) Nicole C Allen et al.   NATURE GENETICS

Regulation of N-methyl-d-aspartate receptors by astrocytic d-serine

(2008) S.H.R. Oliet et al.   NEUROSCIENCE

Mutant mice with reduced NMDA-NR1 glycine affinity or lack of d-amino acid oxidase function exhibit altered anxiety-like behaviors

(2008) Viviane Labrie et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Age and oestrus cycle-related changes in glucocorticoid excretion and wheel-running activity in female mice carrying mutations in the circadian clock genes Per1 and Per2

(2008) Violetta Pilorz et al.   PHYSIOLOGY & BEHAVIOR

Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia

(2008) Viviane Labrie et al.   PSYCHOPHARMACOLOGY

Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes

(2008) Jiajun Shi et al.   SCHIZOPHRENIA RESEARCH

Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia

(2008) Caroline Madeira et al.   SCHIZOPHRENIA RESEARCH

d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats

(2007) Jun-ichi Karasawa et al.   BEHAVIOURAL BRAIN RESEARCH

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine

(2007) Kenji Hashimoto et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Stress-induced changes in sleep in rodents: Models and mechanisms

(2007) Aaron C. Pawlyk et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS